Navigation Links
Neuro Kinetics Receives HHS Therapeutic Discovery Grant to Further Research Into Early Diagnosis of Sports Concussions
Date:11/18/2010

advances is the premise that the eye is the portal to the brain.  Research has shown the detection of abnormal eye reflexes can indicate the presence of over 200 diseases and medical conditions. 

For more than 25 years, NKI has supplied comprehensive neuro-otologic diagnostic tools to audiologists, ENT's, neuro-otologists, neuro-ophthalmologists and neurologists around the globe.  The company's patented products include the I-Portal® NOTC (Neuro-Otologic Test Center), I-Portal® VNG (Video Nystagmography) and I-Portal® VOG (Video Oculography), along with related accessories, software, training and support services. MEDIA CONTACTJohn BuckmanBuckman Communications, for Neuro Kinetics, Inc.+ 1 412-381-2900 or jbuckman@buckman.biz
'/>"/>

SOURCE Neuro Kinetics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sangamo BioSciences Announces Presentation of Phase 2 Data in Amyotrophic Lateral Sclerosis (ALS) at Society for Neuroscience Meeting
2. Nautilus Neurosciences and Tribute Pharmaceuticals Announce Exclusive Canadian License for CAMBIA™ (diclofenac potassium for oral solution) for the Acute Treatment of Migraine
3. NIH-Funded Study Is First to Demonstrate Increased Long-Term Survival With Favorable Neurologic Function Among Patients Receiving CPR Using ACSI ResQPump™ and ResQPOD® CPR Devices
4. Neurologix Reports Third Quarter 2010 Financial Results
5. Reportlinker Adds Neuroprotection - Drugs, Markets and Companies
6. NeuroDerm Initiates Phase 2 Study of ND0801 in Patients with ADD/ADHD
7. NeurogesX Doses First Patient in Phase 2 Clinical Study of NGX-1998 Liquid Capsaicin Formulation
8. Neurocrine Biosciences Reports Third Quarter 2010 Results
9. Pfizers Lyrica® (Pregabalin) Capsules CV Receives Approval for Treatment of Peripheral Neuropathic Pain In Japan
10. Boston Scientific Agrees to Sell Neurovascular Business to Stryker
11. NeurogesX to Hold Conference Call to Discuss Third Quarter 2010 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... 29, 2015 Asterias Biotherapeutics, Inc. (NYSE MKT: ... of regenerative medicine, today announced that it will release ... 10, 2015 after the close of the U.S. financial ... webcast on Monday, August 10, 2015 at 4:30 p.m. ... and corporate developments. For both "listen-only" participants ...
(Date:7/29/2015)... 29, 2015  Depomed, Inc. (NASDAQ: DEPO ) ... Board of Directors, after careful consideration and with ... advisors, has unanimously rejected the purported revised, highly ... plc (NASDAQ: HZNP ) ("Horizon") to acquire ... an all-stock transaction (the "July 21 Proposal"). ...
(Date:7/29/2015)... 29, 2015 Immune Pharmaceuticals Inc. (NASDAQ: IMNP ... up to $21.5 million through two financing agreements. The ... ) ("Hercules"), for a term loan of up to ... Growth Fund ("Discover"), for the sale to Discover of ... Stock") for up to $12 million in gross proceeds ...
Breaking Medicine Technology:Asterias Biotherapeutics to Report Second Quarter Results on August 10, 2015 2Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 2Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 3Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 4Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 5Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 6Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 7Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 8Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 9Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 2Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 3Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 4Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 5Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 6Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 7
... Medical, Inc. (NASDAQ: ICUI ) today announced ... 36th annual meeting of the California Society of Health-System ... company,s ChemoClave® closed system transfer device (CSTD) designed to ... to hazardous drugs is more affordable for hospitals to ...
... FRANCISCO and RIDGEFIELD, Conn., Nov. 8, 2011  Boehringer ... Phase 2 studies evaluating the combination of the company,s ... ribavirin (RBV) in treatment-naive genotype-1 (GT1) hepatitis C virus ... SILEN-C1 studies show that BI 201335 may have ...
Cached Medicine Technology:Breaking Study: ICU Medical, Inc. ChemoClave® System Costs Less to Implement than any Closed System Transfer Device for the Safe Handling of Hazardous Drugs 2Breaking Study: ICU Medical, Inc. ChemoClave® System Costs Less to Implement than any Closed System Transfer Device for the Safe Handling of Hazardous Drugs 3Breaking Study: ICU Medical, Inc. ChemoClave® System Costs Less to Implement than any Closed System Transfer Device for the Safe Handling of Hazardous Drugs 4Sustained Viral Response from Phase 2 Studies of BI 201335, Including Difficult-to-Treat HCV Patient Types 2Sustained Viral Response from Phase 2 Studies of BI 201335, Including Difficult-to-Treat HCV Patient Types 3Sustained Viral Response from Phase 2 Studies of BI 201335, Including Difficult-to-Treat HCV Patient Types 4Sustained Viral Response from Phase 2 Studies of BI 201335, Including Difficult-to-Treat HCV Patient Types 5
(Date:7/29/2015)... ... July 30, 2015 , ... Macro Wealth Management ... through the Smile for a Lifetime program by encouraging their clients to donate their ... by MWM Presidents Dr. Mart McClellan and Tim Streid, who see charitable giving as ...
(Date:7/29/2015)... ... July 30, 2015 , ... In their continuing drive ... of online continuing education courses for Athletic Trainers , HomeCEUConnection.com, today announced ... and Education Sports Medicine Series. , The new online continuing education courses were ...
(Date:7/29/2015)... ... July 29, 2015 , ... If you’re a fan of Vietnamese banh mi ... by the Orange County Register , more than 465,000 pounds of mislabeled meat ... article does not mention any reported illnesses that have been connected to problems reportedly ...
(Date:7/29/2015)... ... 2015 , ... Sports fans young and old at the National Cherry Festival ... Detroit Lions, joined by A Forever Recovery, a holistic treatment center for substance abuse ... Pro Bowl Offensive Lineman Lomas Brown, and Tight End Rob Rubick signed foam footballs, ...
(Date:7/29/2015)... ... July 29, 2015 , ... Conventional theories used by economists for the ... may be able to unlock mysteries about the behavior of microbial life on earth, ... and Columbia University. , The findings, published July 29 in the open access journal ...
Breaking Medicine News(10 mins):Health News:Smile for a Lifetime (S4L) Partners with Macro Wealth Management (MWM) Helping More Children Get Braces 2Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 2Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 3Health News:Three Important Product Liability Realities Offered In Light of News of Recent Product Recalls 2Health News:Three Important Product Liability Realities Offered In Light of News of Recent Product Recalls 3Health News:A Forever Recovery Holds Autograph Event with Former Detroit Lions at Cherry Festival 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 3
... the most feared diseases all around the world. Researchers ... offering adult diabetics an alternative to injections// for controlling ... approved by the FDA. ,If approved, the drug, ... insulin injections taken by millions worldwide. The product works ...
... the study show that increasing intake of the common flavouring ... dieters eat less and reduce cravings brought on by sugar ... of vinegar consumed by 12 healthy subjects and their glucose ... the study, volunteers were given three amounts of vinegar (18, ...
... weight for health, it is equally important to lose weight ... of fruits, vegetables, whole grains and other such nutritious foods// ... and follow and is more effective than the conventional diet ... ,A low-fat, plant-based diet has been found to be ...
... Conventional therapy for this for of cancer is to remove ... liver. Survival for patients// with this type of operation is ... treated this way because the tumors can involve both sides ... tumor that is often found in the lining of the ...
... world is like a stage “, written by William Shakespeare ... read, nice to listen but a little difficult to accept ... given to aging, very little is done to understand the ... would have been embarrassed by the odd behavior of old ...
... 25% of the MRSA infections in the hospital happen in ... The research was published in the latest issue of BMJ// ... serious form of infection is that in which blood stream ... bacteremia by hospital trust, but it has not yet addressed ...
Cached Medicine News:Health News:Exubera could mean the end of an insulin injection era for diabetics 2Health News:Weight loss accomplished by high carbohydrate, vegan diet 2Health News:Combined modality approach for effective treatment and enhanced survival in bile duct cancer 2Health News:Do not regret growing older, It is a privilege denied to many 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: